Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Reinvestment Rate
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting €184.52 Million (capex €170.49 Million plus investments €-14.03 Million) from operating cash flow of €1.69 Billion. See Genertec Universal Medical Group Company free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genertec Universal Medical Group Company Limited Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Genertec Universal Medical Group Company Limited across 4 annual periods. For the full cash flow conversion analysis, see Genertec Universal Medical Group Company (5UM) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year capital reinvestment analysis for Genertec Universal Medical Group Company Limited. See financial flexibility index of Genertec Universal Medical Group Company to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | €1.01 Billion | €5.78 Billion | €988.91 Million | ▼ -87.9% |
| 2024 | 1.44x | €1.64 Billion | €1.14 Billion | €1.26 Billion | ▲ +267.1% |
| 2023 | 0.39x | €1.96 Billion | €4.99 Billion | €896.83 Million | ▲ +4.0% |
| 2022 | 0.38x | €774.64 Million | €2.06 Billion | €608.09 Million | — |